Clearmind Medicine Common Stock Price Prediction
| CMND Stock | USD 0.99 0.03 2.94% |
Momentum 53
Impartial
Oversold | Overbought |
Using Clearmind Medicine hype-based prediction, you can estimate the value of Clearmind Medicine Common from the perspective of Clearmind Medicine response to recently generated media hype and the effects of current headlines on its competitors.
Clearmind Medicine Common Hype to Price Pattern
Investor biases related to Clearmind Medicine's public news can be used to forecast risks associated with an investment in Clearmind. The trend in average sentiment can be used to explain how an investor holding Clearmind can time the market purely based on public headlines and social activities around Clearmind Medicine Common. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Clearmind Medicine's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Clearmind Medicine.
The fear of missing out, i.e., FOMO, can cause potential investors in Clearmind Medicine to buy its stock at a price that has no basis in reality. In that case, they are not buying Clearmind because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Clearmind Medicine after-hype prediction price | USD 0.99 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Clearmind | Build AI portfolio with Clearmind Stock |
Clearmind Medicine After-Hype Price Prediction Density Analysis
As far as predicting the price of Clearmind Medicine at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Clearmind Medicine or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Clearmind Medicine, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Clearmind Medicine Estimiated After-Hype Price Volatility
In the context of predicting Clearmind Medicine's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Clearmind Medicine's historical news coverage. Clearmind Medicine's after-hype downside and upside margins for the prediction period are 0.05 and 5.64, respectively. We have considered Clearmind Medicine's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Clearmind Medicine is extremely dangerous at this time. Analysis and calculation of next after-hype price of Clearmind Medicine Common is based on 3 months time horizon.
Clearmind Medicine Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Clearmind Medicine is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Clearmind Medicine backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Clearmind Medicine, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.07 | 4.65 | 0.00 | 0.01 | 10 Events / Month | 3 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.99 | 0.99 | 0.00 |
|
Clearmind Medicine Hype Timeline
Clearmind Medicine Common is currently traded for 0.99. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. Clearmind is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is estimated to be very small, whereas the daily expected return is currently at 0.07%. %. The volatility of related hype on Clearmind Medicine is about 2703.49%, with the expected price after the next announcement by competition of 0.98. The book value of the company was currently reported as 0.45. The company recorded a loss per share of 1.12. Clearmind Medicine Common had not issued any dividends in recent years. The entity had 1:30 split on the 28th of November 2023. Given the investment horizon of 90 days the next estimated press release will be in about 10 days. Check out Clearmind Medicine Basic Forecasting Models to cross-verify your projections.Clearmind Medicine Related Hype Analysis
Having access to credible news sources related to Clearmind Medicine's direct competition is more important than ever and may enhance your ability to predict Clearmind Medicine's future price movements. Getting to know how Clearmind Medicine's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Clearmind Medicine may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| DRMA | Dermata Therapeutics | 0.03 | 6 per month | 0.00 | (0.04) | 7.69 | (6.35) | 22.00 | |
| JFBR | Jeffs Brands | (1.21) | 9 per month | 13.32 | (0.01) | 15.23 | (20.18) | 121.97 | |
| SPRC | Scisparc | 0.12 | 7 per month | 5.23 | 0.03 | 8.94 | (6.62) | 60.89 | |
| VRAX | Virax Biolabs Group | 0.08 | 21 per month | 0.00 | (0.08) | 5.75 | (6.45) | 24.63 | |
| ZVSA | ZyVersa Therapeutics | 0.12 | 7 per month | 0.00 | (0.18) | 9.38 | (17.95) | 67.27 |
Clearmind Medicine Additional Predictive Modules
Most predictive techniques to examine Clearmind price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Clearmind using various technical indicators. When you analyze Clearmind charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Clearmind Medicine Predictive Indicators
The successful prediction of Clearmind Medicine stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Clearmind Medicine Common, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Clearmind Medicine based on analysis of Clearmind Medicine hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Clearmind Medicine's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Clearmind Medicine's related companies. | 2022 | 2023 | 2024 | 2025 (projected) | Net Debt To EBITDA | 0.62 | 1.11 | 1.28 | 1.22 | Intangibles To Total Assets | 0.02 | 0.0149 | 0.0172 | 0.0163 |
Story Coverage note for Clearmind Medicine
The number of cover stories for Clearmind Medicine depends on current market conditions and Clearmind Medicine's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Clearmind Medicine is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Clearmind Medicine's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Clearmind Medicine Short Properties
Clearmind Medicine's future price predictability will typically decrease when Clearmind Medicine's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Clearmind Medicine Common often depends not only on the future outlook of the potential Clearmind Medicine's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Clearmind Medicine's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 4.3 M | |
| Cash And Short Term Investments | 6.9 M |
Complementary Tools for Clearmind Stock analysis
When running Clearmind Medicine's price analysis, check to measure Clearmind Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearmind Medicine is operating at the current time. Most of Clearmind Medicine's value examination focuses on studying past and present price action to predict the probability of Clearmind Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearmind Medicine's price. Additionally, you may evaluate how the addition of Clearmind Medicine to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| CEOs Directory Screen CEOs from public companies around the world | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |